Nature journal

The National Institute of Allergy and Infectious Diseases co-hosted a workshop on mucosal vaccines for COVID-19, with researchers emphasizing the need for improvement. No COVID-19 mucosal vaccines have been authorized for use in the US or Europe, but at least 44 are in preclinical development. The workshop concluded that research into mucosal vaccine development is a priority, and could lead to improved vaccines for other diseases.

by

The COVID-19 pandemic has had a profound impact on the world, affecting every aspect of life, from work to travel, education to healthcare. While several vaccines have been developed and authorized for emergency use, the race to produce a more effective and convenient vaccine continues. One promising approach is the mucosal COVID-19 vaccine. Unlike traditional … Read more

The National Institute of Allergy and Infectious Diseases hosted a virtual workshop on developing mucosal vaccines for COVID-19, highlighting challenges and opportunities.

by

Since the onset of the COVID-19 pandemic, scientists worldwide have been tirelessly working on the development of vaccines to curb the spread of the virus. While several vaccines have been developed and authorized for use, there is still a need to explore more efficient and effective ways to combat the virus. One promising approach that … Read more

Corona virus: Why there were so few deaths among Ischgl’s inhabitants

by

Wieder is the Austrian tourist town of Ischgl in the headlines. Because researchers led by the virologist Dorothee von Laer have now found that almost every second in the village community had the virus in their bodies. However, only two of Ischgl’s inhabitants died. Is it all-clear? Isn’t the virus that dangerous? The virologist von … Read more